{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:42:42Z","timestamp":1793943762571,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY009339; R01EY030873, P30EY034070"],"award-info":[{"award-number":["R01EY009339; R01EY030873, P30EY034070"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["T32GM008620; F30EY033642"],"award-info":[{"award-number":["T32GM008620; F30EY033642"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA062203"],"award-info":[{"award-number":["P30CA062203"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CHE-1904530"],"award-info":[{"award-number":["CHE-1904530"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>CRISPR\/Cas9-based gene-editing technologies offer promise for treating inherited retinal diseases (IRDs), however safe and efficient ocular delivery of precision editors remains challenging. To address this challenge, we report a class of Coomassie brilliant blue (CBB)-derived lipidoids that bind and deliver proteins. Subretinal injection of Cre complexed with these lipidoids into mT\/mG mice leads to robust recombination in the retinal pigment epithelium and photoreceptors. We employ the CBB-lipidoid platform to deliver adenine base editor (ABE) ribonucleoproteins (RNP). Incorporating CBB lipidoids into liposomes improves delivery efficiency. CBB11 stands out for facilitating precise in vivo ABE-mediated gene editing. Delivery of liposome-CBB11-RNP complexes results in a 120-fold increase in base editing compared to RNP alone and restores the scotopic ERG b-wave response in the rd12 mouse model. These results demonstrate the potential of CBB-augmented, liposome-RNP systems for therapeutic gene editing in the eye, paving the way for single-dose precision medicines to treat IRDs.<\/jats:p>","DOI":"10.1038\/s41467-026-69077-w","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:03:57Z","timestamp":1770473037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A combinatorial synthetic strategy for developing genome-editing protein-delivery agents targeting mouse retina"],"prefix":"10.1038","volume":"17","author":[{"given":"Jianye","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Ho\u0142ubowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Smidak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2181-1182","authenticated-orcid":false,"given":"Yulun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-3659","authenticated-orcid":false,"given":"Samuel W.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin H.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Palczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolline","family":"Rodrigues Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9689-7474","authenticated-orcid":false,"given":"Eleonora","family":"Risaliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-4532","authenticated-orcid":false,"given":"Zhiqian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba H.","family":"Shayegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-602X","authenticated-orcid":false,"given":"Li","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ho\u0142ubowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-254X","authenticated-orcid":false,"given":"Gregory P.","family":"Tochtrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0788-545X","authenticated-orcid":false,"given":"Krzysztof","family":"Palczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"69077_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"69077_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"69077_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"69077_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"69077_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"69077_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41551-021-00788-9","volume":"6","author":"H Jang","year":"2022","unstructured":"Jang, H. et al. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases. Nat. Biomed. Eng. 6, 181\u2013194 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"69077_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu, Z., Yang, H. & Colosi, P. Effect of genome size on AAV vector packaging. Mol. Ther. 18, 80\u201386 (2010).","journal-title":"Mol. Ther."},{"key":"69077_CR8","doi-asserted-by":"publisher","first-page":"110223","DOI":"10.1016\/j.exer.2024.110223","volume":"251","author":"RL Fehrman","year":"2025","unstructured":"Fehrman, R. L., Chern, K. J., Stoltz, K. P. & Lipinski, D. M. The vectors went in two-by-two: Transduction efficiency and tolerability of dual and triple rAAV vector delivery following intravitreal injection for genome-editing applications. Exp. Eye Res. 251, 110223 (2025).","journal-title":"Exp. Eye Res."},{"key":"69077_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55137-6","volume":"16","author":"MS Padilla","year":"2025","unstructured":"Padilla, M. S. et al. Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering. Nat. Commun. 16, 996 (2025).","journal-title":"Nat. Commun."},{"key":"69077_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s41565-024-01680-8","volume":"19","author":"X Lian","year":"2024","unstructured":"Lian, X. et al. Bone-marrow-homing lipid nanoparticles for genome editing in diseased and malignant haematopoietic stem cells. Nat. Nanotechnol. 19, 1409\u20131417 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"69077_CR11","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1021\/acs.molpharmaceut.5c00248","volume":"22","author":"S Dong","year":"2025","unstructured":"Dong, S. et al. Lipid nanoparticles-mediated mRNA delivery to the eye affected by ionizable cationic lipid. Mol. Pharm. 22, 3297\u20133307 (2025).","journal-title":"Mol. Pharm."},{"key":"69077_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"69077_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42948-2","volume":"14","author":"T Wei","year":"2023","unstructured":"Wei, T. et al. Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models. Nat. Commun. 14, 7322 (2023).","journal-title":"Nat. Commun."},{"key":"69077_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"69077_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","volume":"9","author":"R Holubowicz","year":"2025","unstructured":"Holubowicz, R. et al. Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations. Nat. Biomed. Eng. 9, 57\u201378 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"69077_CR16","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","volume":"43","author":"K Chen","year":"2025","unstructured":"Chen, K. et al. Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein. Nat. Biotechnol. 43, 1445\u20131457 (2025).","journal-title":"Nat. Biotechnol."},{"key":"69077_CR17","doi-asserted-by":"publisher","first-page":"e2307796121","DOI":"10.1073\/pnas.2307796121","volume":"121","author":"CA Tsuchida","year":"2024","unstructured":"Tsuchida, C. A., Wasko, K. M., Hamilton, J. R. & Doudna, J. A. Targeted nonviral delivery of genome editors in vivo. Proc. Natl. Acad. Sci. USA 121, e2307796121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69077_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40476-7","volume":"14","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo. Nat. Commun. 14, 4928 (2023).","journal-title":"Nat. Commun."},{"key":"69077_CR19","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1021\/acs.macromol.9b01645","volume":"52","author":"Z Tan","year":"2019","unstructured":"Tan, Z. et al. Block Polymer Micelles Enable CRISPR\/Cas9 Ribonucleoprotein Delivery: Physicochemical Properties Affect Packaging Mechanisms and Gene Editing Efficiency. Macromolecules 52, 8197\u20138206 (2019).","journal-title":"Macromolecules"},{"key":"69077_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121959","volume":"293","author":"JM Metzger","year":"2023","unstructured":"Metzger, J. M. et al. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins. Biomaterials 293, 121959 (2023).","journal-title":"Biomaterials"},{"key":"69077_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw8922","volume":"5","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing. Sci. Adv. 5, eaaw8922 (2019).","journal-title":"Sci. Adv."},{"key":"69077_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17029-3","volume":"11","author":"T Wei","year":"2020","unstructured":"Wei, T., Cheng, Q., Min, Y. L., Olson, E. N. & Siegwart, D. J. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 11, 3232 (2020).","journal-title":"Nat. Commun."},{"key":"69077_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","volume":"2","author":"B Lee","year":"2018","unstructured":"Lee, B. et al. Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat. Biomed. Eng. 2, 497\u2013507 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"69077_CR24","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413\u20137417 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69077_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","volume":"23","author":"PR Cullis","year":"2024","unstructured":"Cullis, P. R. & Felgner, P. L. The 60-year evolution of lipid nanoparticles for nucleic acid delivery. Nat. Rev. Drug Discov. 23, 709\u2013722 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"69077_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0452-8","volume":"17","author":"EY Cho","year":"2019","unstructured":"Cho, E. Y. et al. Lecithin nano-liposomal particle as a CRISPR\/Cas9 complex delivery system for treating type 2 diabetes. J. Nanobiotechnol. 17, 19 (2019).","journal-title":"J. Nanobiotechnol."},{"key":"69077_CR27","doi-asserted-by":"publisher","unstructured":"Riley, R. S. et al. Ionizable lipid nanoparticles for in utero mRNA delivery. Sci. Adv. 7, https:\/\/doi.org\/10.1126\/sciadv.aba1028 (2021).","DOI":"10.1126\/sciadv.aba1028"},{"key":"69077_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X. et al. An ionizable lipid toolbox for RNA delivery. Nat. Commun. 12, 7233 (2021).","journal-title":"Nat. Commun."},{"key":"69077_CR29","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"69077_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00216-008-1996-x","volume":"391","author":"CD Georgiou","year":"2008","unstructured":"Georgiou, C. D., Grintzalis, K., Zervoudakis, G. & Papapostolou, I. Mechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteins. Anal. Bioanal. Chem. 391, 391\u2013403 (2008).","journal-title":"Anal. Bioanal. Chem."},{"key":"69077_CR31","doi-asserted-by":"publisher","first-page":"eabb0310","DOI":"10.1126\/sciadv.abb0310","volume":"6","author":"W Tai","year":"2020","unstructured":"Tai, W., Zhao, P. & Gao, X. Cytosolic delivery of proteins by cholesterol tagging. Sci. Adv. 6, eabb0310 (2020).","journal-title":"Sci. Adv."},{"key":"69077_CR32","doi-asserted-by":"crossref","unstructured":"Ho\u0142ubowicz, R. et al. Precision base and prime editing in the eye using ribonucleoprotein nanoparticles. Nat. Biomed. Eng. 9, 57\u201378 (2024).","DOI":"10.1038\/s41551-024-01296-2"},{"key":"69077_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2506257122","volume":"122","author":"SW Du","year":"2025","unstructured":"Du, S. W. et al. TIGER: A tdTomato in vivo genome-editing reporter mouse for investigating precision-editor delivery approaches. Proc. Natl. Acad. Sci. USA 122, e2506257122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69077_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","volume":"19","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Engineering a precise adenine base editor with minimal bystander editing. Nat. Chem. Biol. 19, 101\u2013110 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"69077_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109916","volume":"27","author":"J Li","year":"2024","unstructured":"Li, J. et al. Comprehensive single-cell atlas of the mouse retina. iScience 27, 109916 (2024).","journal-title":"iScience"},{"key":"69077_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","volume":"5","author":"S Suh","year":"2021","unstructured":"Suh, S. et al. Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing. Nat. Biomed. Eng. 5, 169\u2013178 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"69077_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29490-3","volume":"13","author":"EH Choi","year":"2022","unstructured":"Choi, E. H. et al. In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration. Nat. Commun. 13, 1830 (2022).","journal-title":"Nat. Commun."},{"key":"69077_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265 (2022).","journal-title":"Cell"},{"key":"69077_CR39","doi-asserted-by":"publisher","first-page":"13931","DOI":"10.1093\/nar\/gkae1066","volume":"52","author":"PR Arantes","year":"2024","unstructured":"Arantes, P. R. et al. Dimerization of the deaminase domain and locking interactions with Cas9 boost base editing efficiency in ABE8e. Nucleic Acids Res. 52, 13931\u201313944 (2024).","journal-title":"Nucleic Acids Res."},{"key":"69077_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1126\/science.abb1390","volume":"369","author":"A Lapinaite","year":"2020","unstructured":"Lapinaite, A. et al. DNA capture by a CRISPR-Cas9-guided adenine base editor. Science 369, 566\u2013571 (2020).","journal-title":"Science"},{"key":"69077_CR41","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ophtha.2014.03.006","volume":"121","author":"PA Keane","year":"2014","unstructured":"Keane, P. A. et al. Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology 121, 1706\u20131714 (2014).","journal-title":"Ophthalmology"},{"key":"69077_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0163-7827(83)90004-8","volume":"22","author":"SJ Fliesler","year":"1983","unstructured":"Fliesler, S. J. & Anderson, R. E. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22, 79\u2013131 (1983).","journal-title":"Prog. Lipid Res."},{"key":"69077_CR43","doi-asserted-by":"publisher","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","volume":"18","author":"AG Hamilton","year":"2024","unstructured":"Hamilton, A. G. et al. High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route. ACS Nano 18, 16151\u201316165 (2024).","journal-title":"ACS Nano"},{"key":"69077_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102349","volume":"35","author":"J Pulman","year":"2024","unstructured":"Pulman, J. et al. Direct delivery of Cas9 or base editor protein and guide RNA complex enables genome editing in the retina. Mol. Ther. Nucleic Acids 35, 102349 (2024).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"69077_CR45","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"69077_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2416827121","volume":"121","author":"SW Du","year":"2024","unstructured":"Du, S. W. et al. In vivo photoreceptor base editing ameliorates rhodopsin-E150K autosomal-recessive retinitis pigmentosa in mice. Proc. Natl. Acad. Sci. USA 121, e2416827121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69077_CR47","doi-asserted-by":"crossref","unstructured":"Geilenkeuser, J. et al. Engineered nucleocytosolic vehicles for loading of programmable editors. Cell188, 2637\u20132655 (2025).","DOI":"10.1016\/j.cell.2025.03.015"},{"key":"69077_CR48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/978-3-030-27378-1_83","volume":"1185","author":"F Mazzoni","year":"2019","unstructured":"Mazzoni, F., Tombo, T. & Finnemann, S. C. No difference between age-matched male and female C57BL\/6J mice in photopic and scotopic electroretinogram a- and b-wave amplitudes or in peak diurnal outer segment phagocytosis by the retinal pigment epithelium. Adv. Exp. Med. Biol. 1185, 507\u2013511 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"69077_CR49","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"69077_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/978-1-4939-8669-9_21","volume":"1834","author":"G Palczewska","year":"2019","unstructured":"Palczewska, G., Kern, T. S. & Palczewski, K. Noninvasive two-photon microscopy imaging of mouse retina and retinal pigment epithelium. Methods Mol. Biol. 1834, 333\u2013343 (2019).","journal-title":"Methods Mol. Biol."},{"key":"69077_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nm.3590","volume":"20","author":"G Palczewska","year":"2014","unstructured":"Palczewska, G. et al. Noninvasive two-photon microscopy imaging of mouse retina and retinal pigment epithelium through the pupil of the eye. Nat. Med. 20, 785\u2013789 (2014).","journal-title":"Nat. Med."},{"key":"69077_CR52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"69077_CR53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman, J. L., Raguram, A., Newby, G. A. & Liu, D. R. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat. Biotechnol. 38, 620\u2013628 (2020).","journal-title":"Nat. Biotechnol."},{"key":"69077_CR54","doi-asserted-by":"publisher","unstructured":"Zhang, J. et al. A combinatorial synthetic strategy for developing genome-editing protein-delivery agents targeting mouse retina, Dataset in Dryad, https:\/\/doi.org\/10.5061\/dryad.d51c5b0hd (2025).","DOI":"10.5061\/dryad.d51c5b0hd"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69077-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69077-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:03:05Z","timestamp":1773676985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69077-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69077"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69077-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.P. is a consultant for Polgenix Inc. and AbbVie Inc., and serves on the Scientific Advisory Board of Hyperion Eye Ltd. K.P. and G.P.T. are equity holders in Eyesomer Therapeutics. D.R.L. is a consultant and\/or equity owner for Prime Medicine, Beam Therapeutics, Pairwise Plants, and nChroma Bio, companies that use or deliver genome-editing or epigenome-engineering agents. All other authors have declared that no competing interests exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2479"}}